However, given a recent report implicating loss of EZH2 and subsequent reduction of histone H3K27 trimethylation in acquired resistance to tyrosine kinase inhibitors (TKIs) and cytotoxic drugs in AML due to derepression of HOX genes (48), cautious selection of specific patient groups is required. This evidence concerns the gene EZH2 and acute myeloid leukemia.